Nanosonics Limited · ASX:NAN
Nanosonics — Wilson HTM Life Sciences Conference 2007
19 slides from Nanosonics's conference presentation, Oct 17, 2007
Slide 1: Tapping into International Markets: R&D is Only Half the Challenge
For personal use only “Tapping into International Markets” “R&D is Only Half the Challenge” 1 October 2007
Slide 2: Nanosonics' Opportunity
Nanosonics’ Opportunity For personal use only • Nanosonics has patented a breakthrough disinfection platform technology • The Company’s first products disinfect medical instruments utilising our novel technology: - faster, more effectively and more safely • Market reaction to our technology and prod
Slide 3: What we planned to do 2 years ago
What we planned to do 2 years ago For personal use only ¾ PLAN to PLAN • Battles are won or lost in the preparation, plan to plan ¾ ENOUGH CAPITAL • 24 months of capital to allow for slippage and control of our own destiny ¾ RIGHT PEOPLE • Recruit DNA from companies who have been there ¾ MARKET PART
Slide 4: Disinfection Market drivers
Disinfection Market drivers For personal use only Major trends in modern medicine: 1. Hospital acquired Infection - 150,000 Australians a year infected in hospital, 7,000 deaths - England, 300,000 people, £1B cost annually 2. Growing use of minimally invasive instruments - high tech equipment, with
Slide 5: What we are trying to mitigate
What we are trying to mitigate For personal use only EDMONTON – “More firings appear to be in the works as the fallout continues from a hospital sterilization scandal that has rocked Alberta's health-care system and forced 3,000 former patients to be tested for HIV and hepatitis. The 25-bed hospital
Slide 6: Current disinfection methods
Current disinfection methods For personal use only • Disinfection methods depend on: - invasiveness of medical procedures, instrument construction 6
Slide 7: First product for Ultrasound Probes
First product for Ultrasound Probes For personal use only 7
Slide 8: Competitive advantages
Competitive advantages For personal use only 8
Slide 9: Our Initial Challenge
Our Initial Challenge For personal use only 1. Focus, Focus, Focus 2. Adapt platform technology to meet market gaps and large, profitable applications 9
Slide 10: Commercialisation strategy (Big C)
Commercialisation strategy (Big C) For personal use only 3. Do the homework and sensitivity analysis 10
Slide 11: Commercialisation strategy (Big C)
Commercialisation strategy (Big C) For personal use only 4. Find the “sweet spot” product 5. Develop the channel and product simultaneously 11
Slide 12: "Sweet Spot" product
“Sweet Spot” product For personal use only “Un-sterilised equipment was used to perform neurosurgery on a patient at Queen Elizabeth Hospital after medical staff mistakenly rinsed an ultrasound probe in water instead of in an antiseptic solution” South China Morning Post – October 2007 12
Slide 13: Define the Market
Define the Market For personal use only • Disinfection of medical instruments is a defined market • We wanted to be the ipod in a market consisting of Gramophones • However, current practices or approaches are accepted … almost “tolerated” • Research determined that the majority of medical modalitie
Slide 14: Market Development Strategies
Market Development Strategies For personal use only • Identifying the channels stakeholders and key influencers • Engage these stakeholders in a systematic and sustained campaign • Determine key stakeholder and their values, needs and perceptions 14
Slide 15: The importance of OEMs
The importance of OEMs For personal use only Medical Equip They make OEMs Ultrasound Probes • Siemens • Philips • GE • Hitachi • Toshiba • Etc Nanosonics Device Disinfects these Complex Probes 15
Slide 16: Covering all the bases
Covering all the bases For personal use only 16
Slide 17: Roll-out programme Q3/Q4 FY08
Roll-out programme Q3/Q4 FY08 For personal use only 17
Slide 18: Don't forget the processes
Don’t forget the processes For personal use only • Supply chain infrastructure • After sales regulatory and product support • Establish distribution network (B2B) • Customs and import duty issues • Establish financial, order entry, billing and tax systems • Establish reference sites and product “tra
Slide 19: In summary
In summary For personal use only • Focus on the C whilst you are still in R&D • Engage Global Instrument manufactures (partners) before you have a product – be persistent and informative • Identify “friendly” industry evangelists early – Doctors, associations – find mentors and real partners • Devel
Nanosonics — Wilson HTM Life Sciences Conference 2007 on 6ix